Načítá se...
Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa
A major contributor to fatalities in cystic fibrosis (CF) patients stems from infection with opportunistic bacterium Pseudomonas aeruginosa. As a result of the CF patient’s vulnerability to bacterial infections, one of the main treatment focuses is antibiotic therapy. However, the highly adaptive na...
Uloženo v:
| Vydáno v: | ACS Infect Dis |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716366/ https://ncbi.nlm.nih.gov/pubmed/30444345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.8b00288 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|